These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 9680345

  • 21. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG, Caron PC, Miller WH, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP, Scheinberg DA.
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [Abstract] [Full Text] [Related]

  • 22. Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
    Ding W, Li YP, Nobile LM, Grills G, Carrera I, Paietta E, Tallman MS, Wiernik PH, Gallagher RE.
    Blood; 1998 Aug 15; 92(4):1172-83. PubMed ID: 9694705
    [Abstract] [Full Text] [Related]

  • 23. PML/RAR alpha transcripts monitored by polymerase chain reaction in acute promyelocytic leukemia during complete remission, relapse and after bone marrow transplantation.
    Perego RA, Marenco P, Bianchi C, Cairoli R, Urbano M, Nosari AM, Muti G, Morra E, Del Monte U.
    Leukemia; 1996 Feb 15; 10(2):207-12. PubMed ID: 8637228
    [Abstract] [Full Text] [Related]

  • 24. Acute promyelocytic leukemia: clinical relevance of two major PML-RAR alpha isoforms and detection of minimal residual disease by retrotranscriptase/polymerase chain reaction to predict relapse.
    Huang W, Sun GL, Li XS, Cao Q, Lu Y, Jiang GS, Zhang FQ, Chai JR, Wang ZY, Waxman S.
    Blood; 1993 Aug 15; 82(4):1264-9. PubMed ID: 8394752
    [Abstract] [Full Text] [Related]

  • 25. Prospective minimal residual disease monitoring to predict relapse of acute promyelocytic leukemia and to direct pre-emptive arsenic trioxide therapy.
    Grimwade D, Jovanovic JV, Hills RK, Nugent EA, Patel Y, Flora R, Diverio D, Jones K, Aslett H, Batson E, Rennie K, Angell R, Clark RE, Solomon E, Lo-Coco F, Wheatley K, Burnett AK.
    J Clin Oncol; 2009 Aug 01; 27(22):3650-8. PubMed ID: 19506161
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RARalpha fusion transcripts.
    Applegate TL, Iland HJ, Mokany E, Todd AV.
    Clin Chem; 2002 Aug 01; 48(8):1338-43. PubMed ID: 12142392
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia.
    Zhu HH, Qin YZ, Lai YY, Shi HX, Liu YR, Jiang B, Huang XJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug 01; 21(4):872-8. PubMed ID: 23998577
    [Abstract] [Full Text] [Related]

  • 33. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
    Burnett AK, Russell NH, Hills RK, Bowen D, Kell J, Knapper S, Morgan YG, Lok J, Grech A, Jones G, Khwaja A, Friis L, McMullin MF, Hunter A, Clark RE, Grimwade D, UK National Cancer Research Institute Acute Myeloid Leukaemia Working Group.
    Lancet Oncol; 2015 Oct 01; 16(13):1295-305. PubMed ID: 26384238
    [Abstract] [Full Text] [Related]

  • 34. Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
    Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, Bloomfield CD, Appelbaum FR, Tallman MS, Slack JL, Willman CL.
    Blood; 2003 Apr 01; 101(7):2521-8. PubMed ID: 12468436
    [Abstract] [Full Text] [Related]

  • 35. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X, Seshire A, Rüster B, Bug G, Beissert T, Puccetti E, Hoelzer D, Henschler R, Ruthardt M.
    Haematologica; 2007 Mar 01; 92(3):323-31. PubMed ID: 17339181
    [Abstract] [Full Text] [Related]

  • 36. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E, Bonanad S, López JA, Martín G, Martínez J, Sanz GF, Gomis F, Pérez ML, Senent ML, Larrea L, Bolufer P, Sanz MA.
    Sangre (Barc); 1996 Jun 01; 41(3):189-94. PubMed ID: 8755206
    [Abstract] [Full Text] [Related]

  • 37. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto.
    Specchia G, Lo Coco F, Vignetti M, Avvisati G, Fazi P, Albano F, Di Raimondo F, Martino B, Ferrara F, Selleri C, Liso V, Mandelli F.
    J Clin Oncol; 2001 Oct 15; 19(20):4023-8. PubMed ID: 11600603
    [Abstract] [Full Text] [Related]

  • 38. Monitoring of minimal residual disease in children with acute promyelocytic leukemia by RT-PCR detecting PML/RARalpha chimeric gene: a retrospective study of clinical feasibility.
    Suzuki H, Imaizumi M, Sato A, Yoshinari M, Rikiishi T, Endo M, Takano T, Shimizu T, Hatae Y, Fujimoto T, Hayashi Y, Iinuma K.
    Tohoku J Exp Med; 2001 Feb 15; 193(2):127-39. PubMed ID: 11318028
    [Abstract] [Full Text] [Related]

  • 39. Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
    Grimwade D, Howe K, Langabeer S, Burnett A, Goldstone A, Solomon E.
    Leukemia; 1996 Jan 15; 10(1):61-6. PubMed ID: 8558940
    [Abstract] [Full Text] [Related]

  • 40. Role of autologous bone marrow transplantation as consolidation therapy in acute promyelocytic leukemia patients in complete remission.
    Ottaviani E, Martinelli G, Testoni N, Visani G, Tani M, Tura S.
    Haematologica; 1998 Nov 15; 83(11):1051-5. PubMed ID: 9864933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.